Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ATRA | FIMM | pan-cancer | AAC | 0.057 | 0.7 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |